Clinical-Stage Companies / Hamad Medical Corporation

Hamad Medical Corporation

Pre-Approval PRO BETA

🔴

Stale Activity

No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 2/21/2024

Total Trials

Phase 3

Phase 2

Recruiting

134

Score

Pipeline by Phase

Phase 3

Phase 2

Phase 1

Therapeutic Focus

Bronchiolitis Gastroenteritis Labor Pain Obstetric Pain Analgesia

Clinical Trials (21)

NCT03846973 Phase 3 COMPLETED

Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid

Started: 12/2/2018

NCT03040765 Phase 3 TERMINATED

Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis

Started: 5/14/2018

NCT03079505 Phase 3 TERMINATED

Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia

Started: 8/3/2017

NCT02442427 Phase 3 COMPLETED

"Palivizumab Therapy for RSV-bronchiolitis"

Started: 9/1/2014

NCT04643678 Phase 2 COMPLETED

Anakinra in the Management of COVID-19 Infection

Started: 10/30/2020

NCT04445246 Phase 2 COMPLETED

Inhaled Iloprost for Suspected COVID-19 Respiratory Failure

Started: 5/23/2020

NCT03380507 Phase 2 TERMINATED

Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock

Started: 3/17/2018

NCT02145520 Phase 2 COMPLETED

Efficacy of Magnesium Sulfate in the Treatment of Bronchiolitis

Started: 10/1/2012

NCT03523221 Phase 1 RECRUITING

Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis

Started: 4/15/2018

NCT01395589 Phase 1 COMPLETED

Rapid vs Maintenance Vitamin D Supplementation in Deficient Children With Asthma to Prevent Exacerbations.

Started: 2/1/2011

NCT01065272 Phase 1 COMPLETED

Dexamethasone in the Treatment of Bronchiolitis in Patients With Either Eczema and or Family History of Asthma

Started: 2/1/2010

NCT02473887 Phase 1 COMPLETED

Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting

Started: 9/1/2014

NCT06266767 Phase 4 COMPLETED

Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia

Started: 2/21/2024

NCT05061654 Phase 4 WITHDRAWN

CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients

Started: 8/1/2022

NCT04199572 Phase 4 COMPLETED

Synergistic Effect Of Parenteral Diclofenac And Paracetamol In The Pain Management Of Acute Limb Injuries

Started: 10/16/2022

NCT04330872 Phase 4 COMPLETED

An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke.

Started: 8/26/2019

NCT02897856 Phase 4 COMPLETED

Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures

Started: 9/1/2016

NCT02049346 Phase 4 COMPLETED

Comparison Among Erythropoietin Stimulating Agents

Started: 3/1/2012

NCT02868697 Phase 4 COMPLETED

Management of Tunneled Catheter Thrombosis in Hemodialysis Patients: Prospective Study From Qatar

Started: 11/1/2013

NCT02187614 Phase 4 COMPLETED

Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management

Started: 8/1/2014

NCT01165866 Phase 4 COMPLETED

Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis

Started: 6/1/2008

Drug Candidates

Levobupivacaine and Fentanyl Dexamethasone Oral Ceftolozane-tazobactam IV Diclofenac and Paracetamol Anakinra Inhaled ILOPROST Triple therapy group Tranexamic Acid Enteric Coated Aspirin Tablet Plain Aspirin

Activity Status: Stale

Last Trial Started: 2/21/2024

Last Trial Ended: 10/5/2024

Trials (12 months): 0

Completed Trials: 16

Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.